Canonical Question
PainPharm – NMDA Antagonists
Master answer
| PROPOFOL | KETAMINE | |
|---|---|---|
| Resp | – Respiratory depression – Apnoea – Decreased RR, TV, MV, FRC | – Mild respiratory stimulation – Respiratory depression if rapid IV administration – Increased secretions – Maintenance of pharygo-laryngeal reflexes > Laryngospasm – Bronchodilation > Likely Ca channel mediated via R-ketamine isomer |
| CVS | – Peripheral vasodilation – Bradycardia – Hypotension | – Indirect sympathomimetic effects → elevation of MAP > Due to inhibition of noradrenaline reuptake – Direct cardiodepressant effects |
| CNS | – Sedation – Decreased cerebral blood flow | – Increased cerebral blood flow – Increased cerebral O2 consumption – Sedation – Hallucinations – Emergence phenomena |
| GIT | – Nausea (although usually anti-emetic) | – Nausea > Due to serotonin reuptake inhibition |
| Other | – Propofol infusion syndrome > Rhabdomyolysis > Metabolic acidosis > Steatohepatitis – Injection site pain – Anaphylaxis – Leukocytosis | – Anaphylaxis – Increased muscle tone |
Exam appearances
| Exam | Exact wording | Relationship | Success |
|---|---|---|---|
| 2010B Q07 | List the adverse properties of Propofol and Ketamine | historical_member | — |